Mapping metabolic brain activity in three models of hepatic encephalopathy.
about
Low-light-level therapy as a treatment for minimal hepatic encephalopathy: behavioural and brain assessment.Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability.Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic encephalopathy.
P2860
Mapping metabolic brain activity in three models of hepatic encephalopathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@en
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@nl
type
label
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@en
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@nl
prefLabel
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@en
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@nl
P2093
P2860
P50
P356
P1476
Mapping metabolic brain activity in three models of hepatic encephalopathy.
@en
P2093
Jaime Arias
Marta Méndez
Natalia Arias
P2860
P304
P356
10.1155/2013/390872
P577
2013-03-14T00:00:00Z